MRI useful and reliable in surgical planning of patients with rectal cancer

June 6, 2008

3T MRI can accurately stage, and help surgeons plan sphincter-sparing surgery in patients with rectal cancer, according to a recent study conducted by researchers at Qilu Hospital of Shandong University in Shandong, China.

"Recently, MRI has been increasingly accepted by radiologists, surgeons and patients to image the rectum because of its superior soft tissue contrast and multi-planar capability," said Chuanfu Li, MD, lead author of the study.

"Most rectal MRI studies have used field strength of 1.5 Tesla or less. Only two recent studies focus on 3T MRI for diagnosing and staging rectal cancer. "No standard protocol is available for 3T MRI of the rectum, which may cause inconsistent diagnostic accuracy among institutions. The purpose of this study was to evaluate the image quality of various 3T MR sequences for preoperative staging and planning of sphincter sparing rectal cancer resection," he said.

The study included 39 patients (23 men, 15 women), who underwent 3T MRI. According to the study, rectal carcinoma was identified on MRI and confirmed histologically in all 38 (should this be 39?) patients. The study showed that MRI findings correctly identified 31 of 32 resectable cases (96.9%), and sphincter-sparing approaches were accurately chosen on the basis of the MRI findings.

"In addition to accurate tumor staging, MRI contributes to surgical planning by showing the relationship of tumor to the sphincter and levator ani muscles on good quality coronal and sagittal images," said Dr. Li. "This technique can give the surgeons a higher level of confidence and ," he said.

The study appears in a recent issue of the American Journal of Roentgenology.

Source: American Roentgen Ray Society

Explore further: MRI predicts survival in locally advanced rectal cancer

Related Stories

MRI predicts survival in locally advanced rectal cancer

August 29, 2011
A new study has shown that magnetic resonance imaging (MRI) used to evaluate responses to pre-surgery (neo-adjuvant) chemotherapy or radiation may predict survival among patients with advanced rectal cancer. The findings ...

Pre-op MRI of margins predicts rectal cancer outcomes

December 8, 2013
(HealthDay)—Preoperative high-resolution magnetic resonance imaging (MRI) assessment of circumferential resection margin (CRM) status predicts survival and other disease progression outcomes in patients with rectal cancer, ...

Age tied to spread of rectal cancer to lymph nodes

October 28, 2012
Rectal cancer is more likely to spread to the lymph nodes in younger patients, according to new findings that Fox Chase Cancer Center researchers will be presenting on October 29 at the American Society for Radiation Oncology's ...

Tissue spacers reduce risk of rectal injury for prostate cancer patients

April 29, 2011
Injecting a tissue spacer in the prostate-rectal inter-space is an effective way to reduce the rectal dose for prostate cancer patients receiving radiation therapy, according to research presented April 30, 2011, at the Cancer ...

Focal therapy offers middle ground for some prostate cancer patients

March 5, 2013
Men with low-risk prostate cancer who previously had to choose between aggressive treatment, with the potential for significant side effects, and active surveillance, with the risk of disease progression, may have a new option. ...

MRI locates prostate cancer recurrence at extremely low PSA levels

April 29, 2011
A pelvic MRI scan with IV contrast and rectal balloon is highly effective in identifying local recurrence even at low PSA values in prostate cancer patients with a rising or persistently elevated PSA after prostatectomy, ...

Recommended for you

Lung cancer triggers pulmonary hypertension

November 17, 2017
Shortness of breath and respiratory distress often increase the suffering of advanced-stage lung cancer patients. These symptoms can be triggered by pulmonary hypertension, as scientists at the Max Planck Institute for Heart ...

Researchers discover an Achilles heel in a lethal leukemia

November 16, 2017
Researchers have discovered how a linkage between two proteins in acute myeloid leukemia enables cancer cells to resist chemotherapy and showed that disrupting the linkage could render the cells vulnerable to treatment. St. ...

Computer program finds new uses for old drugs

November 16, 2017
Researchers at the Case Comprehensive Cancer Center at Case Western Reserve University School of Medicine have developed a computer program to find new indications for old drugs. The computer program, called DrugPredict, ...

Pharmacoscopy improves therapy for relapsed blood cancer in a first clinical trial

November 16, 2017
Researchers at CeMM and the Medical University of Vienna presented a preliminary report in The Lancet Hematology on the clinical impact of an integrated ex vivo approach called pharmacoscopy. The procedures measure single-cell ...

Wider sampling of tumor tissues may guide drug choice, improve outcomes

November 15, 2017
A new study focused on describing genetic variations within a primary tumor, differences between the primary and a metastatic branch of that tumor, and additional diversity found in tumor DNA in the blood stream could help ...

A new strategy for prevention of liver cancer development

November 14, 2017
Primary liver cancer is now the second leading cause of cancer-related death worldwide, and its incidences and mortality are increasing rapidly in the United Stated. In late stages of the malignancy, there are no effective ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.